tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IONS Stock Latest News

Arrowhead files complaint for declaratory judgment against Ionis
The FlyArrowhead files complaint for declaratory judgment against Ionis
4d ago
ARWR
IONS
Ionis Pharmaceuticals: Buy Rating Backed by Breakthrough Therapy Designation and Promising Clinical Results for ION582
PremiumRatings
Ionis Pharmaceuticals: Buy Rating Backed by Breakthrough Therapy Designation and Promising Clinical Results for ION582
6d ago
IONS
Ionis Pharmaceuticals granted breakthrough therapy designation to ION582
PremiumThe Fly
Ionis Pharmaceuticals granted breakthrough therapy designation to ION582
6d ago
IONS
Ionis Pharmaceuticals price target raised to $80 from $70 at RBC Capital
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $80 from $70 at RBC Capital
11d ago
IONS
Ionis Pharmaceuticals’ Olezarsen Shows Strong Potential in Billion-Dollar Market, Earning Buy Rating from Analyst
PremiumRatings
Ionis Pharmaceuticals’ Olezarsen Shows Strong Potential in Billion-Dollar Market, Earning Buy Rating from Analyst
11d ago
IONS
Why Did IONIS Stock (IONS) Surge to a Four-Year High?
PremiumMarket NewsWhy Did IONIS Stock (IONS) Surge to a Four-Year High?
11d ago
IONS
Cautious Optimism for Ionis Pharmaceuticals Amid Promising Olezarsen Trial Results and Pending Regulatory Hurdles
Premium
Ratings
Cautious Optimism for Ionis Pharmaceuticals Amid Promising Olezarsen Trial Results and Pending Regulatory Hurdles
12d ago
IONS
Ionis Pharmaceuticals: Balancing Promising Trial Results with Market Uncertainties
Premium
Ratings
Ionis Pharmaceuticals: Balancing Promising Trial Results with Market Uncertainties
12d ago
IONS
Ionis Pharmaceuticals price target raised to $84 from $69 at Citi
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $84 from $69 at Citi
12d ago
IONS
Ionis Pharmaceuticals: Promising Pipeline and Potential Profitability Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Promising Pipeline and Potential Profitability Drive Buy Rating
12d ago
IONS
Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital
PremiumThe Fly
Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital
12d ago
IONS
Promising Investment: Ionis Pharmaceuticals’ Olezarsen Surpasses Expectations with Phase 3 CORE Trial Success
PremiumRatings
Promising Investment: Ionis Pharmaceuticals’ Olezarsen Surpasses Expectations with Phase 3 CORE Trial Success
12d ago
IONS
Ionis Pharmaceuticals price target raised to $78 from $58 at Barclays
PremiumThe FlyIonis Pharmaceuticals price target raised to $78 from $58 at Barclays
13d ago
IONS
Ionis Pharmaceuticals: Strong Buy Rating Backed by Promising Phase 3 Study Results for Olezarsen
Premium
Ratings
Ionis Pharmaceuticals: Strong Buy Rating Backed by Promising Phase 3 Study Results for Olezarsen
13d ago
IONS
Morgan Stanley ups Ionis target on ‘best-case scenario’ data
Premium
The Fly
Morgan Stanley ups Ionis target on ‘best-case scenario’ data
13d ago
IONS
Ionis Pharmaceuticals price target raised to $70 from $55 at Needham
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $70 from $55 at Needham
13d ago
IONS
Ionis Pharmaceuticals rises 31.2%
PremiumThe Fly
Ionis Pharmaceuticals rises 31.2%
13d ago
IONS
Ionis Pharmaceuticals’ Olezarsen Triumphs in Phase 3 Trials, Analyst Raises Price Target
PremiumRatings
Ionis Pharmaceuticals’ Olezarsen Triumphs in Phase 3 Trials, Analyst Raises Price Target
13d ago
IONS
Ionis Pharmaceuticals rises 26.5%
PremiumThe Fly
Ionis Pharmaceuticals rises 26.5%
13d ago
IONS
Ionis Pharmaceuticals price target raised to $96 from $83 at Jefferies
PremiumThe FlyIonis Pharmaceuticals price target raised to $96 from $83 at Jefferies
13d ago
IONS
Ionis Pharmaceuticals price target raised to $95 from $70 at H.C. Wainwright
Premium
The Fly
Ionis Pharmaceuticals price target raised to $95 from $70 at H.C. Wainwright
13d ago
IONS
Ionis Pharmaceuticals’ Olezarsen Shows Promising Phase III Results in Reducing Triglycerides and Pancreatitis Risk
Premium
Ratings
Ionis Pharmaceuticals’ Olezarsen Shows Promising Phase III Results in Reducing Triglycerides and Pancreatitis Risk
13d ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >